Found: 37
Select item for more details and to access through your institution.
Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221108693
- By:
- Publication type:
- Article
Adenoid Cystic Carcinoma of Lobar Bronchial Origin: 20-Year Experience at a Single Institution.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4408, doi. 10.1245/s10434-022-11590-5
- By:
- Publication type:
- Article
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061948
- By:
- Publication type:
- Article
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211061948
- By:
- Publication type:
- Article
Postoperative radiotherapy for completely resected Masaoka stage III thymoma: a retrospective study of 65 cases from a single institution.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-199
- By:
- Publication type:
- Article
Postoperative radiotherapy for completely resected Masaoka stage III thymoma: a retrospective study of 65 cases from a single institution.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer.
- Published in:
- Radiation Oncology, 2012, v. 7, n. 1, p. 119, doi. 10.1186/1748-717X-7-119
- By:
- Publication type:
- Article
Postoperative Intensity-Modulated Radiotherapy Improved Survival in Lymph Node-Positive or Stage III Thoracic Esophageal Squamous Cell Carcinoma.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, n. 3, p. 97, doi. 10.1159/000375391
- By:
- Publication type:
- Article
A Single Center Analysis of Thymic Neuroendocrine Tumors †.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4944, doi. 10.3390/cancers14194944
- By:
- Publication type:
- Article
A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.781340
- By:
- Publication type:
- Article
Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.618776
- By:
- Publication type:
- Article
Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced nonsmall-cell lung cancer: protocol for a randomized phase II trial (InTRist study).
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1341584
- By:
- Publication type:
- Article
Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1281888
- By:
- Publication type:
- Article
Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non–Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 12, p. e1918070, doi. 10.1001/jamanetworkopen.2019.18070
- By:
- Publication type:
- Article
Treatment outcomes of patients with stage III non–small cell lung cancer and interstitial lung diseases receiving intensity‐modulated radiation therapy: A single‐center experience of 85 cases.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 11, p. 1583, doi. 10.1111/1759-7714.14418
- By:
- Publication type:
- Article
Development and validation of a prediction model using molecular marker for long‐term survival in unresectable stage III non‐small cell lung cancer treated with chemoradiotherapy.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 3, p. 296, doi. 10.1111/1759-7714.14218
- By:
- Publication type:
- Article
Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score‐matched analysis.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 12, p. 1831, doi. 10.1111/1759-7714.13971
- By:
- Publication type:
- Article
Postoperative radiotherapy for pathological stage IIIA‐N2 non‐small cell lung cancer with positive surgical margins.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 2, p. 227, doi. 10.1111/1759-7714.13749
- By:
- Publication type:
- Article
Impact of thoracic radiation therapy after chemotherapy on survival in extensive‐stage small cell lung cancer: A propensity score‐matched analysis.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 799, doi. 10.1111/1759-7714.13001
- By:
- Publication type:
- Article
Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 23, p. 5423, doi. 10.1002/cncr.26206
- By:
- Publication type:
- Article
Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB--III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. e2151, doi. 10.1002/onco.13914
- By:
- Publication type:
- Article
Postoperative Radiotherapy in Pathological T2–3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. e701, doi. 10.1634/theoncologist.2019-0276
- By:
- Publication type:
- Article
Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
- Published in:
- Oncologist, 2016, v. 21, n. 12, p. 1530, doi. 10.1634/theoncologist.2016-0155
- By:
- Publication type:
- Article
Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectomy: A post hoc analysis of a randomized controlled trial.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.936684
- By:
- Publication type:
- Article
Radical thoracic radiotherapy may provide favorable outcomes for stage IV non-small cell lung cancer.
- Published in:
- Thoracic Cancer, 2016, v. 7, n. 2, p. 182, doi. 10.1111/1759-7714.12305
- By:
- Publication type:
- Article
Role of radiotherapy in treating patients with primary malignant mediastinal non-seminomatous germ cell tumor: A 21-year experience at a single institution.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 4, p. 399, doi. 10.1111/1759-7714.12190
- By:
- Publication type:
- Article
Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 3, p. 346, doi. 10.1111/1759-7714.12186
- By:
- Publication type:
- Article
Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial.
- Published in:
- OncoTargets & Therapy, 2013, v. 6, p. 1589, doi. 10.2147/OTT.S50945
- By:
- Publication type:
- Article